We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » SFDA Proposes ‘Blacklist’ to Shame Drugmakers into Higher Standards
SFDA Proposes ‘Blacklist’ to Shame Drugmakers into Higher Standards
June 7, 2012
Stung by the chromium-contaminated drug capsule scandal, China’s State Food and Drug Administration (SFDA) is proposing to “blacklist” executives who oversee pharma companies found to produce substandard or counterfeit drugs.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor